How can we reduce the mortality of invasive pneumococcal disease?

T. Welte (Hanover, Germany)

Source: Annual Congress 2013 –European Respiratory Review: what's hot in pulmonary medicine
Session: European Respiratory Review: what's hot in pulmonary medicine
Session type: Symposium
Number: 1410
Disease area: Respiratory critical care

Slide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Welte (Hanover, Germany). How can we reduce the mortality of invasive pneumococcal disease?. Annual Congress 2013 –European Respiratory Review: what's hot in pulmonary medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
The problem of early mortality in pneumococcal pneumonia: a study of risk factors
Source: Eur Respir J 2015; 46: 561-564
Year: 2015

CURB-65 clinical prediction rule in invasive pneumococcal disease (IPD)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005

The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012

Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events
Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis
Year: 2019

Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects
Source: Eur Respir J 2005; 26: 1086-1091
Year: 2005

Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004

Should pneumococcal vaccines be used to prevent LRTI?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009

Chronic pulmonary diseases and the epidemiology of invasive pneumococcal infection
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012

Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications
Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives
Year: 2008

Immunosuppression is associated with lower morbidity and mortality in the 2017/2018 influenza epidemic
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019

Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types
Source: Eur Respir J 2014; 44: 1646-1657
Year: 2014

Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved.
Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer
Year: 2018

Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013

Influenza and pneumoccocal vaccination protect against all cause mortality in COPD
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008

Impact of initial antibiotic choice on mortality from pneumococcal pneumonia
Source: Eur Respir J 2006; 27: 1010-1019
Year: 2006

No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016

Results of vaccination against pneumococcal infection in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007

Effects of pneumococcal vaccine in patients with chronic respiratory disease
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007